About GATT Technologies BV
GATT Technologies BV is a company based in Nijmegen (Netherlands) founded in 2011 by Johan Bender and Dennis Vriezema. GATT Technologies BV has raised $11.36 million across 2 funding rounds from investors including Oost NL, EIC Fund and Johnson & Johnson Innovation. GATT Technologies BV operates in a competitive market with competitors including Cohera Medical, Neomend, Sealonix, OptMed and BORAYER, among others.
- Headquarter Nijmegen, Netherlands
- Founders Johan Bender, Dennis Vriezema
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$11.36 M (USD)
in 2 rounds
-
Latest Funding Round
Not available
-
Investors
Oost NL
& 2 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of GATT Technologies BV
Unlock access to complete
Unlock access to complete
Funding Insights of GATT Technologies BV
GATT Technologies BV has successfully raised a total of $11.36M across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in GATT Technologies BV
GATT Technologies BV has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Oost NL, EIC Fund and Johnson & Johnson Innovation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Locked | Locked | Locked | |
|
Sector-agnostic VC firm investing in geographies such as the Netherlands
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for GATT Technologies BV
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by GATT Technologies BV
Investment portfolio details for GATT Technologies BV
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - GATT Technologies BV
Detailed financials for GATT Technologies BV
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Gatt Technologies Bv Comparisons
Peer comparison for GATT Technologies BV
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of GATT Technologies BV
GATT Technologies BV operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cohera Medical, Neomend, Sealonix, OptMed and BORAYER, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Develops innovative surgical adhesives and sealants for medical use.
|
|
| Locked | Locked | Locked |
Provider of air leak sealant for thoracic surgery
|
|
| Locked | Locked | Locked |
Developer of hemostatic sealants for surgeries
|
|
| Locked | Locked | Locked |
Biocompatible polymers and genitourinary therapeutics are developed and commercialized.
|
|
| Locked | Locked | Locked |
Biomaterials for surgery and wound repair are developed.
|
Detailed competitors of GATT Technologies BV
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Gatt Technologies Bv
Complete news archive for GATT Technologies BV
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about GATT Technologies BV
GATT Technologies BV was founded in 2011 and raised its 1st funding round 9 years after it was founded.
GATT Technologies BV is headquartered in Nijmegen, Netherlands. It is registered at Nijmegen, Gelderland, Netherlands.
Johan Bender is the current CEO of GATT Technologies BV. They have also founded this company.
GATT Technologies BV is a funded company, having raised a total of $11.36M across 2 funding rounds to date.
GATT Technologies BV was founded in 2011 in Nijmegen, Netherlands, as a specialty firm in the medical device sector. Focus is placed on developing General Adhesive Tissue Tape (GATT) using polyoxazoline polymers in modified forms for surgical applications. The technology platform supports construction of sealants tailored to various procedures, with operations centered on polymer innovation and tissue adhesion solutions.